Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?Expert Review of Neurotherapeutics · 2026-07-22Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response ModelbioRxiv · 2026-07-22Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertaintybioRxiv · 2026-07-20Psilocybin restores behavior and 5-HT signaling while reducing microglial density after chronic traumatic brain injury in rats.Cell reports. Medicine · 2026-07-20A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults.medRxiv · 2026-07-18Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia.Neuropsychopharmacology · 2026-07-17Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot StudymedRxiv · 2026-07-13CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology · 2026-07-06EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-11Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-06-03Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-05-31Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Unknown journal · 2026-05-28Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.Journal of psychopharmacology (Oxford, England) · 2026-04-30Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-29A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-27Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Unknown journal · 2026-04-25Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.Unknown journal · 2026-03-19Psychological support in psychedelic-assisted therapy clinical trials: A systematic reviewJournal of Psychopharmacology · 2026-03-19Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative reviewSchizophrenia Research · 2026-03-12Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-09Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.Unknown journal · 2026-02-23Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trialBJPsych Open · 2026-02-15Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments.Unknown journal · 2026-02-13Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11India’s Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric TherapeuticsIndian Journal of Psychological Medicine · 2026-02-04Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.Unknown journal · 2026-01-31Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-14Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.Unknown journal · 2026-01-06Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacinNeuroscience Applied · 2025-12-31Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trialNeuroscience Applied · 2025-12-31Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depressionNeuroscience Applied · 2025-12-31Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to musicNeuroscience Applied · 2025-12-31A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-22The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-21Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-18Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot studyBJPsych Open · 2025-12-14Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06The emotional architecture of the psychedelic brain.Trends in cognitive sciences · 2025-10-31Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication StudyResearch Square · 2025-09-24Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.International journal of molecular sciences · 2025-09-13Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased AgonismFigshare · 2025-09-12Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".Unknown journal · 2025-09-02Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Unknown journal · 2025-08-14Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Unknown journal · 2025-07-31Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Unknown journal · 2025-07-17Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.Unknown journal · 2025-07-06What fMRI studies say about the nature of the psychedelic effect: a scoping review.Unknown journal · 2025-06-30Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Australia’s psychedelic experiment: reflections from a psychiatrist clinical researcherAustralasian Psychiatry · 2025-06-25Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-09Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushroomsAmerican Journal of Ophthalmology Case Reports · 2025-06-01Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-05-31Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical PopulationmedRxiv · 2025-05-28Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.Unknown journal · 2025-05-27Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats.Unknown journal · 2025-05-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2025-04-21Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Polysubstance Use Profiles Among the General Adult Population, United States, 2022.Unknown journal · 2025-03-18Psychedelics Align Brain Activity with ContextbioRxiv · 2025-03-10Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.Unknown journal · 2025-03-07Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.Unknown journal · 2025-01-18Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-15The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2024-12-31High-quality draft genomes of ecologically and geographically diverse Psilocybe speciesMicrobiology Resource Announcements · 2024-12-26ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21The safety of psilocybin-assisted psychotherapy: A systematic review.Unknown journal · 2024-12-12Legal and Ethics Concerns of Psilocybin as Medicine.Unknown journal · 2024-12-11Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-09Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.Unknown journal · 2024-12-09Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Impact of psilocybin on cognitive function: A systematic review.Unknown journal · 2024-09-30Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin TreatmentbioRxiv · 2024-09-22Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.Unknown journal · 2024-09-11Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided ImageryClinical Endocrinology and Metabolism · 2024-08-29The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or settingmedRxiv · 2024-08-25Psilocybin for clinical indications: A scoping review.Unknown journal · 2024-08-12Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithiumbioRxiv · 2024-08-08Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-23Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019Drug and Alcohol Dependence · 2024-06-30Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingbioRxiv · 2024-06-28Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global HealthcareTrends in Medical Research · 2024-06-27Licit use of illicit drugs for treating depression: the pill and the process.Unknown journal · 2024-06-16Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin ReceptorUNC Libraries · 2024-06-06Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseasesUnknown journal · 2024-05-31Medical Uses and Adverse Effects of PsilocybinThe Primary Care Companion For CNS Disorders · 2024-05-26Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanismsMolecular Psychiatry · 2024-04-26300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot studyUnknown journal · 2024-04-23The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-21Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortexAuthorea Preprints · 2024-04-21Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Unknown journal · 2024-04-05[Psychedelic psychiatry].Unknown journal · 2024-04-03Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Rapid-acting antidepressant drugs modulate affective bias in rats.Unknown journal · 2024-01-08The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Unknown journal · 2023-12-31Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depressionResearch Square · 2023-12-27Is there credible evidence to assert psilocybin-assisted therapy for depression?Unknown journal · 2023-12-19Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Unknown journal · 2023-11-29Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdalaNeuropsychopharmacology · 2023-09-25Manic episode following psilocybin use in a man with bipolar II disorder: a case reportFrontiers in Psychiatry · 2023-09-21Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of PsilocybinCureus · 2023-09-12Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in MalaysiaJournal of Addictive Diseases · 2023-08-03Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-19A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18A systematic review to assess the use of psilocybin in the treatment of headachesUnknown journal · 2023-07-18Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Unknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Unknown journal · 2023-06-12Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.Unknown journal · 2023-03-01The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Therapeutic effect of psilocybin in addiction: A systematic review.Unknown journal · 2023-02-08Acute psilocybin enhances cognitive flexibility in ratsbioRxiv · 2023-01-08Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational InsightsChemistrySelect · 2023-01-01An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.Journal of psychoactive drugs · 2022-12-31"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.Journal of psychoactive drugs · 2022-12-31Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serumJournal of Psychedelic Studies · 2022-12-06Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International Journal of Molecular Sciences · 2022-11-15A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27Conformational Landscape and Properties of Psilocybin: A Computational ApproachChemistrySelect · 2022-10-03Expectancy in placebo-controlled trials of psychedelics: if so, so what?Psychopharmacology · 2022-09-30P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-08-31Use of psychedelics in the Czech Republic: results of recent population surveys.Central European Journal of Public Health · 2022-08-31The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus · 2022-08-31Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.Journal of Psychedelic Studies · 2022-08-04Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.The Journal of Nervous and Mental Disease · 2022-07-31Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implicationsbioRxiv · 2022-07-22Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-12Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.Unknown journal · 2022-07-10Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-06-30A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-06-30Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).Journal of Fungi · 2022-06-01Serotonin toxicity of serotonergic psychedelics.Psychopharmacology · 2022-05-31Skepticism About Recent Evidence that Psilocybin Opens Depressed MindsPsyArXiv · 2022-04-27Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.Unknown journal · 2022-04-26Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.Neuroscience Applied · 2022-03-06Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.Unknown journal · 2022-03-06Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?Unknown journal · 2022-02-06[Are psychedelics fast acting antidepressant agents?]Unknown journal · 2022-01-31Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.Unknown journal · 2022-01-18Conformational Analysis of Psilocybin: A Computational ApproachSSRN Electronic Journal · 2021-12-31Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.International journal of molecular sciences · 2021-11-29Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.Croatian Medical Journal · 2021-09-30Treating addiction with psychedelics - are we waking up?Unknown journal · 2021-08-12Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.Unknown journal · 2021-07-22Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?Preprints.org · 2021-06-27Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-09Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-06Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in Pharmacology · 2021-02-25Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT).Unknown journal · 2020-11-24Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.Unknown journal · 2020-09-04Psychedelic science in post-COVID-19 psychiatryIrish Journal of Psychological Medicine · 2020-08-18Psychedelic treatment of functional neurological disorder: a systematic review.Unknown journal · 2020-05-10Long-term effects of psychedelic drugs: A systematic review.Unknown journal · 2020-03-15Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.Frontiers in psychiatry · 2019-12-31P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-11-30The psychedelic renaissance: the next trip for psychiatry?Unknown journal · 2019-09-22Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in micebioRxiv · 2019-08-31Entheogens in Christian art: Wasson, Allegro, and the Psychedelic GospelsJournal of Psychedelic Studies · 2019-05-31Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.Unknown journal · 2019-05-31Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and PsilocinThe Microscope · 2018-12-31Dimensions of consciousness and the psychedelic state.Neuroscience of Consciousness · 2018-09-18Psychedelics, Meditation, and Self-Consciousness.Frontiers in Psychology · 2018-09-03The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31Convergent evolution of psilocybin biosynthesis by psychedelic mushroomsbioRxiv · 2018-07-24Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-23Psilocybin and Mental Health-Don't Lose Control.Frontiers in Psychiatry · 2018-07-02Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific Reports · 2017-10-12Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.Unknown journal · 2017-06-04Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.Unknown journal · 2017-05-07Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.Scientific Reports · 2017-04-18Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGUnknown journal · 2016-05-26PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportUnknown journal · 2016-05-26Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.Cephalalgia · 2015-04-21[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].PubMed · 2013-10-31Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.Psychopharmacology · 2012-07-26Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.Unknown journal · 2007-01-31[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].Unknown journal · 2006-12-31Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A ReceptorThe FASEB Journal · 2006-02-28Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.European journal of emergency medicine: official journal of the European Society for Emergency Medicine · 2005-11-30